| Abstract: |
The expression of neutral glycosphingolipids (GSL) in 37 B‐cell neoplasms [7 acute lymphocytic leukemia (ALL), 5 Burkitt's lymphoma (BL), 7 chronic lymphocytic leukemia (CLL), 5 diffuse, poorly differentiated lymphoma (DPDL), 6 diffuse histiocytic lymphoma (DHL), 3 hairy‐cell leukemia (HCL), and 4 multiple myeloma (MM)] was examined. Patterns of expression of simple (GlcCer, LacCer) and globo‐series GSL (Gb3, Gb4,) were found for each tumor type. In addition, pre‐B ALL expressed the neo‐lacto series GSL, paragloboside, which was not significantly seen at later stages of maturation. As a group, leukemias expressed about 10 times higher ratios of simple GSL to Globo‐series GSL as compared to lymphomas, regardless of stage of differentiation. Significant amounts of GSL of other series were not found except in one CLL which contained asialo‐GM2. GSL phenotype in these cells was not grossly affected by cell genotype since pre‐B ALL containing Philadelphia chromosome t(9q;22q) translocations were similar to other ALL; and DHL with t(8q;14q) translocations had GSL patterns similar to other DHL samples and dissimilar to GSL patterns found in Burkitt's lymphomas with t(8q;14q). Differences in GSL expression among the different types of B‐cell neoplasm suggested that GSL patterns form a phenotypic map that may complement the traditional glycoprotein immunophenotypic map and contribute to our understanding of the biology of these diseases and B‐cell differentiation. Copyright © 1991 Wiley‐Liss, Inc., A Wiley Company |
| Keywords: |
clinical article; controlled study; human tissue; comparative study; antigen expression; phenotype; genotype; b cell lymphoma; lymphoma, b-cell; antibodies, monoclonal; chromatography, high pressure liquid; chromosome aberrations; glycosphingolipid; b cell leukemia; glycosphingolipids; chromosome disorders; leukemia, b-cell; chromatography, thin layer; human; priority journal; article; support, non-u.s. gov't; translocation (genetics)
|
